CREDIT SUISSE AG 13D/13G Filings for Evelo Biosciences, Inc. (EVLO)

CREDIT SUISSE AG 13D and 13G filings for Evelo Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-02
1:43 pm
Purchase		2022-12-3113GEvelo Biosciences, Inc.
EVLO		CREDIT SUISSE AG183,919
3.350%		5,595increase
(+3.14%)		Filing
2022-02-14
1:25 pm
Purchase		2021-12-3113GEvelo Biosciences, Inc.
EVLO		CREDIT SUISSE AG178,324
6.670%		43,049increase
(+31.82%)		Filing
2021-02-12
4:16 pm
Purchase		2020-12-3113GEvelo Biosciences, Inc.
EVLO		CREDIT SUISSE AG135,276
5.860%		135,276increase
(New Position)		Filing